Jane Street Group, LLC Cytosorbents Corp Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.7 - $1.01 $23,246 - $33,541	-33,209 Reduced 71.18%	13,446 $9,000
Q1 2024 May 15, 2024	BUY	$0.86 - $1.07 $40,123 - $49,920	46,655 New	46,655 $44,000
Q1 2023 May 15, 2023	BUY	$1.79 - $4.17 $111,826 - $260,512	62,473 New	62,473 $210,000
Q4 2021 Feb 15, 2022	SELL	$4.05 - $8.11 $45,319 - $90,750	-11,190 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$7.0 - $9.71 $119,007 - $165,079	-17,001 Reduced 60.31%	11,190 $91,000
Q2 2021 Aug 16, 2021	BUY	$7.55 - $9.42 $212,842 - $265,559	28,191 New	28,191 $213,000
Q4 2020 Feb 17, 2021	SELL	$7.65 - $8.98 $120,036 - $140,905	-15,691 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$7.37 - $11.54 $115,642 - $181,074	15,691 New	15,691 $125,000

16.7M

15.4K

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $42.3M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.